Incredible as it may seem, even the Milan Court of Appeal (which ten years ago had recognised non-pecuniary damages for inconvenience caused by train delays) has ruled that the fear of death caused by Philips’ communications must be dealt with through ordinary legal proceedings rather than a class action. The reason is that everyone suffers […]

CPAP Europe announces that on December 12, 2025, the 1st instance Court of Milan dismissed our class action complaint. The reason is not on the merits of the case: the Court sees a lack of homogeneity among the proposed class, due to the complexity and diversity of heads of damages (exposure to risk; personal injury; […]

The Court of Milan has adjourned the hearing in the CPAP class action against Philips, originally scheduled for 3 April 2025, postponing it to 19 June 2025. Reasons for the adjournment: -insufficient number of judges in the division -excessive workload. This postponement highlights the understandable difficulties faced by the judicial system following the introduction of […]

CPAP Europe makes accessible to the public the subtitled videos in various languages of the Italian television investigations of “Report” and the German ones of “Panorama”.

The Milan Court has decided to postpone the first hearing of the class action against Philips to April 3, 2025, accepting the request from the defense team.

RAI 3 TV investigative tv show “Report” will feature a segment on December 15, 2024 @20:30 (CET), examining the Philips CPAP recall. The episode will explore the health risks, documented injuries, Philips handling of the situation, and the ongoing class action lawsuit.

The renowned investigative program Panorama 3 explores how approximately 30,000 people from Germany have decided to participate in the European process against Philips for damages from defective respiratory devices. The video is now available to European audiences with subtitles in these languages: DE, IT, EN, SP, FR.

The Global Justice Network (GJN) has responded to Philips CEO Roy Jakobs’ comments about the European class action lawsuit regarding recalled Respironics medical devices. The lawsuit represents potentially over one million users and highlights serious health concerns about toxic chemicals in device components. GJN is demanding accountability, transparency, and compensation for patients exposed to harmful health risks from these medical devices.

The Philips Respironics European Class Action represents thousands of users exposed to toxic medical devices. Many of them reporting health issues from device use. By end of 2024 the recall initiated in 2021 (after many years of hiding the defects) has not been completed.

The first court hearing in the EU Milan class action is scheduled for December 19, 2024. This session will provide a crucial platform for parties to present their initial positions. Outcomes will guide the case’s next steps. Key updates will be shared afterward.

Philips has agreed to a $1.075 billion settlement for U.S. personal injury claims related to recalled CPAP devices. Separate European proceedings are underway, addressing a different legal context. The U.S. settlement covers personal injury claims only. Further information may be found in official announcements.

Clients who register on the CPAP Europe website enter a preliminary assessment phase for the class action. Formal inclusion in the case will depend on the Milan court’s ruling of admissibility. This initial step ensures clients’ situations are considered from the start by the class representatives, their lawyers, consultants and team of medical experts. For updates, please check our NEWS page.